How would you consolidate a patient with primary refractory double hit lymphoma with secondary CNS involvement?
At the time of initial diagnosis, there was no clear CNS involvement. When it became clinically apparent disease was refractory to EPOCH, there was CSF involvement. Now clinically responding to R-DHAOx. Would you extrapolate from studies like ZUMA-7 and TRANSFORM and go to CART, or consider thiotepa-based auto if CR is achieved? Limited co-morbidities and excellent performance status.
Community PollStarted
How would you treat a patient with primary refractory double hit lymphoma with secondary CNS involvement?
20 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Hematology · Keck School of Medicine of USC
Answered on · Updated on
Thiotepa-based transplants are particularly rough. We haven't had good outcomes with them in terms of relapse and mortality is much higher than BEAM or Mel autos.
Having said that, this patient has chemo-refractory disease. The initial concern with CAR-T in primary CNS or secondary involvement was th...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · University of Maryland Cancer Center
Answered on · Updated on
I would extrapolate from the 2L CAR-T trials and will offer CAR-T therapy assuming that his CNS disease is relatively under control.
Join for free or sign in to see the full answer